Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 cases.International journal of surgical oncology · 2013
   Pooled it
2. Frequency and Characteristics of Gastrointestinal Diseases in Patients With Neurofibromatosis.JGH open : an open access journal of gastroenterology and hepatology · 2025
   Article
3. RareFrontiers in molecular biosciences · 2022
   Article
4. Advanced pharmacological therapies for neurofibromatosis type 1-related tumors.Acta bio-medica : Atenei Parmensis · 2020
   Article
5. A Huge Pelvic-Abdominal Malignant GIST Tumour in a Patient with Neurofibromatosis Type 1: Case Report and Literature Review.Case reports in oncological medicine · 2020
   Article
6. Somatic pharmacogenomics of gastrointestinal stromal tumor.Cancer drug resistance (Alhambra, Calif.) · 2019
   Review
7. Impact of germline and somatic missense variations on drug binding sites.The pharmacogenomics journal · 2017
   Article
8. Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I.Journal of gastroenterology · 2016
   Article
9. The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.Endocrine · 2014
   Review
10. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations.International journal of clinical and experimental pathology · 2012
    Review
11. Neoplasms associated with germline and somatic NF1 gene mutations.The oncologist · 2012
    Review
12. Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1.Journal of the Korean Surgical Society · 2011
    Article
13. Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists.Journal of Cancer · 2011
    Article
14. Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2010
    Review
15. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.Journal of cancer research and clinical oncology · 2009
    Article
16. Gastrointestinal bleeding and cutaneous nodules.Proceedings (Baylor University. Medical Center) · 2008
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

11 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as